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Primitive Human Hematopoietic Cells Displaying Differential Efflux of the Rhodamine 123 Dye Have Distinct Biological Activities
By Nobuko Uchida, Jesse Combs, Shirley Chen, Esmail Zanjani, Ron Hoffman, and Ann Tsukamoto
Human bone marrow (BM) CD34+ cells were stained with the vital dye, rhodamine 123 (Rh1231, and analyzed for their biological properties based on the level of dye retention. Heterogeneous rhodamine staining is seen within the CD34' population, and the staining patterns differ dramatically between fetal BM (FBM), adult BM (ABM) and mobilized peripheral blood (MPB). Kinetic analysis of the efflux of Rh123 from ABM CD34+ cells showed that efflux of Rh123 was most rapid from the most primitive Thy-l+ subset. The efflux of Rh123 couM be inhibited by verapamil, suggesting that rhodamine efflux from primitive hematopoietic cells is primarily due to the P-glycoprotein (P-gp) pump or another intracellular transport system affected b y verapamil. When four CD34+ subpopulations were plated onto SySl BM stromal cell cocultures after l t o 2 weeks, only wells plated with CD34+Thy-1+Rh123l0 (low-level Rh123 retention) or CD34+Thy-1+Rh123m'd (mid-level Rh123 retention) cells maintained greater than 50% of cells in an uncommitted CD34+33-stage. CD34+Lin-(lineage-negative) cells were fractionated based on Rh123 dye staining into Rh123h' (high-level Rh123 retention), Rh123m'd, and Rh123' O and deposited as single cells into long-term SySl BM stromal cell cultures. The Rh123m'd fraction had immense early proliferative activity in vitro, but lost the ability to form cobblestone areas after 5 t o 6 weeks HE VITAL DYE, rhodamine 123 (Rh123), has been used to identify subsets of hematopoietic progenitor cells. Extensive studies using mouse"5 and h u m a P bone marrow (BM) cells have shown that subpopulations of cells that retain low levels of Rh123 (Rh123'") appear to contain the most primitive hematopoietic progenitor cells. In normal mouse BM, Rh123'" cells contain primitive long-term repopulating hematopoietic stem cells (HSCs), which are enriched for pre-colony-forming unit-spleen (pre-Cm-S) a~tivity.~.~." In contrast, cells that stain brightly for Rh123 (Rl-1123~) contain the majority of day-l2 CFU-S, day-8 CFU-S, and hematopoietic progenitor cells. Increased staining for Rh123 has thus been shown to correlate directly with hematopoietic maturatioddifferentiation.
Rh123 accumulates preferentially in mitochondria, and was first believed to reflect mitochondria numbers andor activity:.'"'' Mitochondria in Rh123++ cells are bigger than in Rh123'" cells. ' In this view, a subset of HSCs would have few or inactive mitochondria and thus would be considered quiescent. Subsequently, Chaudhary and RoninsonI3 showed that decreased Rh123 staining could also be due to increased expression of an energy-dependent transmembrane efflux pump, P-glycoprotein, the product of the multidrug resistance gene (MDR). In their analysis, they showed that Rh123 staining of human hematopoietic cells is inversely correlated with expression of the MDR gene. Moreover, they showed that decreased Rh123 staining was not due to decreased initial dye uptake, but instead to a rapid efflux of the dye out of BM cells that were sensitive to P-gp inhibitors such as verapamil and reserpine.
We have previously reported that a rare subset of in culture. In contrast, the Rh123'" fraction proliferated more slowly but sustained long-term in vitro hematopoiesis as evidenced by continued cobblestone area-forming cells (CAFC) activity for at least 6 weeks. The Rh123h' fraction showed a plating efficiency similar to that of the Rh123" or Rh123mid fractions but did not extensively proliferate in vitro and did not show evidence of CAFC activity. We predicted from these in vitro results that the Rh123'" subset possesses long-term engrafting potential. Indeed, on transplantation into the SCID-hu bone assay, all long-term engrafting potential and multilineage differentiation potential resided within the Rh123'0""'d but not Rh123hi subset. Furthermore, human marrow subpopulations derived from chimeric sheep after in utero transplantation with CD34+Thy-lcLin-cells were reisolated based on Rh123 staining. Again, CD34+Lin-subsets showing Rh123'0'm'd had long-term growth in culture, whereas Rh123h'CD34+Lin-cells did not. These results show that, after injection of CD34+Thy-l+Lin-cells into an in utero microenvironment, primitive CD34+ cells maintain a Rh123 phenotype that correlates with their in vitro CAFC activity. Thus, Rh123 staining is an effective way t o define functional subsets of primitive hematopoietic cell populations. 0 1996 by The American Society of Hematology.
1+Lin-cells contain cobblestone area-forming cells (CAFC), as detected in long-term BM cultures (LTBMCs), and are capable of producing B-lymphoid and myeloid cells on transplantation into SCID-hu mi~e.'.'~''~ Independently, Craig et all6 have shown that long-term culture-initiating cell (LTC-IC) activity is enriched in CD34'Thy-1 + cells. In the mouse, CAFC activity has been shown to correlate with long-term repopulating potential in lethally irradiated animal~.'~"* In vivo, these human CD34+Thy-l+Lin-cells have the ability to produce CD4' and CD8+ T cells, CD19' B cells, and CD14+, C D W , or CD33' myeloid cells and CD34+ progenitor cell^.^^'^^'^^'^ MO reover, using an in utero transplant model into fetal sheep, these cells have been shown to home and to seed the sheep marrow microenvironment and produce long-term chimerism." We show here that Rh123 is rapidly transported out of the most primitive human CD34+Thy-lf cells, and that this efflux is inhibited by verapamil. The inverse correlation of Thy-l expression and Rh123 dye retention also enables isolation of primitive cells based on Rh123 staining intensity. Moreover, we show that the distinct Rh123 subsets, Rh123hi, Rh123m'd, and Rh123'', show unique biological properties.
MATERIALS AND METHODS

Human hematopoietic cell preparation.
Bones from 18-to 20-week-old fetuses were obtained from Advanced Biological Resources (Oakland, CA) and the Anatomical Gift Foundation (Folkston, GA) by elective abortion after obtaining informed consent. FBM cell suspensions were harvested by flushing split long bones, ABM aspirates were obtained from the posterior iliac crest of healthy adult volunteers after informed consent, according to criteria established by the Institutional Review Boards at the Scripps Clinic (San Diego, CA), Stanford Medical Center (Palo Alto, CA), and the University of Nevada Medical Center (Reno, NV). Low-density (<1.077 g/ pL) mononuclear FBM and ABM cells were isolated using FicollHypaque (Pharmacia, Piscataway, NJ). In some cases, CD34' ABM cells were positively selected before FACS (Becton Dickinson Immunocytometry Systems, San Jose, CA) isolation using affinity columns (Cell Pro, Bothell, WA) or paramagnetic beads (CD34 selection kit; Miltenyi, Sunnyvale, CA). Leukapheresed MPB samples were obtained from multiple myeloma patients treated at the University of Arkansas Medical Center, with informed consent of the patients. These patients underwent mobilization with cyclophosphamide at 6 g/m' at day 0. followed by GM-CSF at 0.25 mg/m'. Red blood cells in leukapheresis MPB samples were lysed with 0.83% ammonium chloride lysis buffer for S to 10 minutes before further staining.
Rh123 staining. The staining procedure for Rh123 has been described previou~lyl~~ and was modified as follows. A I-mg/mL stock solution of Rh123 (Molecular Probes, Eugene, OR) was prepared in ethanol and kept at -20°C in the dark. FBM, ABM, and MP9 cells were resuspended at 10h/mL or less in buffer (Hanks balanced salt solution, RPMI with HEPES, or phosphate-buffered saline) containing 2% fetal calf serum and then incubated with Rh123 at 0.1 pg/mL for 30 minutes at 37°C. The cells were washed and incubated at 37°C for 40 minutes to allow cells to efflux Rh123 dye. The cells were washed again and stained with monoclonal antibodies. Fluorescence intensity of Rh123 was analyzed in the fluorescein isothiocyanate (FITC) channel after setting compensation between FITC and phycoerythrin (PE) channels.
Antibodies. CD34 antigen was detected by staining cells with anti-CD34 (Tuk3, mouse IgG3, from Dr A. Ziegler, University of Berlin, Berlin, Germany) and Texas Red-conjugated goat antimouse IgG3 (Southern Biotechnology Associates, Birmingham, AL). APCand sulfa-rhodamine-conjugated F(ab'), Tuk-3 reagents were prepared at SyStemix (Palo Alto, CA). Thy-l expression was detected by staining cells with anti-Thy-l (GM201, mouse IgG1, from Dr W. Retting, Ludwig Cancer Research Institute, New York, NY) and PE-conjugated goat antimouse IgGl (Caltag, South San Francisco, CA). The following PE-conjugated lineage-marker antibodies were used to define lineage-negative (Lin-) populations: anti-CD19 for B-lineage, anti-CD2 for T-lineage, anti-CD14 and -CD16 for myelomonocytic lineages (Becton Dickinson), and anti-glycophorin A (Immunotech, Westbrook, ME) for erythroid lineage. The cells were incubated for 20 minutes on ice for each step. After the final wash, cells were resuspended in Hanks balanced salt solution containing 1 pg/mL propidium iodide. The labeled cells were analyzed and sorted with a dual-laser FACStar plus or Vantage (Becton Dickinson Immunocytometry Systems). Dead cells were excluded from analysis by their propidium iodide staining characteristics. After sorting, CD34' subpopulations were reanalyzed by FACS before in vitro and in vivo assays.
Rh123 dye eflux analysis. ABM cells were prepared as described earlier, and myelomonocytic cells were further depleted by anti-CD15 magnetic beads prepared at SyStemix. After Rh123 staining, cells were incubated 0 to 3.5 hours at 37°C with Rh123 dyefree media. To block efflux activity by P-glycoprotein, various concentrations of verapamil (Sigma, St Louis, MO) were used. Then cells were stained for CD34 and Thy-l and analyzed by FACS.
In vitro short-term and long-term CAFC assays. Sorted CD34' subsets were cultured on a preestablished monolayer of a mouse stromal cell line (SyS I ) in 96-well flat-bottom plates as previously de~cribed'.~' in the presence of 50 ng/mL human leukemia inhibitory factor (LIF) and 10 ng/mL human interleukin-6. Cultures were fed weekly by replacing 50% of spent culture medium with an equal volume of fresh medium: 50% Iscove's modified Dulbecco's medium (JRH Bioscience, Lenexa, KS), 50% RPMI with 10% fetal calf serum (High Clone Laboratory, Logan, UT), 4 X 10" m o m 2-mercaptoethanol, IO mmollL HEPES, 100 U/mL penicillin-streptomycin, and 4 mmol/L glutamine (JRH Bioscience). For short-term assays, sorted cells were plated ( I to 2 X lo4 cells/well) in 96-well plates. The cultured cells were harvested 1 week after plating and analyzed for CD34, CD33, and CD19 expression by FACS. For CAFC assays (weeks 3 to g), CD34+Lin-Rh123'", Rh123""', and Rh123h' subsets were plated at I to 15 cells/well by an automated cell-deposition unit (ACDU) into 96-well plates. Linear regression analysis of the proportion of negative wells at each cell concentration was used to determine the frequency of CAFC at 3, 4, S , and 6 to 8 weeks. In addition, plating efficiency was defined as the percent of cells that showed any kind of proliferation, including cobblestone areas or cluster formation and macrophage growth during the scoring period ( 2 3 weeks) SCID-hu bone assay. SCID-hu bone assays were performed as described previously.*"" One or two human fetal bone fragments were implanted subcutaneously into the mammary fat pads of SCID mice under methoxyflurane anesthesia with intramuscular injection of a mixture of ketamine hydrochloride (50 mgkg) and zylazine hydrochloride (25 mgkg; SCID-hu bone mice). Five to 12 weeks after the fetal bone implantation, SCID-hu bone mice received irradiation in a single dose of 3.5 Gy. Subsequently, HLA-mismatched sorted cell populations were injected (10-pL vol) directly into the human bone fragment using a Hamilton syringe. SCID-hu bone mice were maintained for 7 to 9 weeks after injection and were then killed to harvest cells from the implanted fetal bones. The harvested cells were stained and analyzed for the presence of human cells using monoclonal antibodies to pan-HLA marker (W6/32), donor-specific HLA. in combination with FITC-or PE-conjugated anti-CD19, anti-CD33, or anti-CD34 monoclonal antibodies by FACScan.
Sheep in utero trunsplantution and resorting of humun cells from sheep BM. Human CD34+Thy-I'Lin-ABM cells were transplanted into 60-day-old sheep fetuses as previously des~ribed."~'~ BM from the iliac crest from one sheep chimera was harvested approximately 200 days after in utero transplantation.2" Human CD34' cells were positively selected, stained, and effluxed for Rh123 dye and stained for CD34 and lineage markers. Human CD34+Lin-cells were sorted and deposited into 96-well plates containing a SySl feeder layer by ACDU as described earlier, and CAFC frequency at weeks 3 to 6 was calculated.
RESULTS
Differential
Rh123 staining of FBM, ABM, and MPB. Mononuclear cells obtained from €%M, ABM, and cytokine MPB were stained with Rh 123 and with monoclonal antibodies to CD34 and Thy-1. A detailed analysis of the rhodamine profile of CD34+ cells was performed (Fig 1A to C ) ..
Rhodamlne 123
in Rh123 staining between FBM, ABM, and MPB. The levels of Rh123'""""' CD34' cells in FBM, ABM, and MPB CD34' cells were 1596, 42%, and 7996, respectively, and appear to increase from FBM to ABM to MPB. Although the level of 80% to 90% of MPB CD34' cells are Rh123'"'"'"'. The CD34' gated cells were also analyzed for expression of Thy-l versus Rh123 (Fig ID to F) . As shown by Craig et all6 for ABM, there is an inverse correlation between Thy-I expression and Rh123 dye retention. The present analysis indicates that there is a CD34'Thy-I'Rh123h' population in equal proportion to the CD34'Thy-1 'Rh123'" fraction in FBM (Fig ID) . By contrast, virtually all CD34'Thy-I' cells from ABM and MPB are Rh123'""'"" (Fig IE and F) . Thus. in ABM and MPB, Rh123'""'"dCD34' cells include the entire Thy-l + subset and some Thy-I cells, and can also be used to identify a more restricted subset of CD34' cells that contain a primitive HSC population.
Kinetics and inhibition of Rh123 efJIux. We wanted to determine whether the low levels of Rh123 dye retention of CD34'Thy-I' cells were due to its efflux, presumably by P-gp. Analysis of Rh I23 dye incorporation and the kinetics of its release by ABM CD34'Thy-I + cells was examined by flow-cytometric analysis. ABM cells were stained with Rh 123 for 30 minutes at 37°C. All cells were Rhl23-bright at time 0 (Fig 2B) . To initiate dye efflux, cells were incubated at 37°C in the absence of dye. The kinetics of Rh123 efflux of CD34' cells was measured by monitoring the proportion of Rh1 23'" and Rh 123"'"''hi in these cells after various periods of incubation up to 3.5 hours (Fig 2) . As the efflux time increased, a dramatic shift from Rh I 23h' to Rh 123'" occurred within the Thy-l' subset of CD34' cells, indicating that these cells had a higher capacity to exclude Rh123 dye.
Verapamil has been shown to be an effective inhibitor of P-gp activity,'5"6 and efflux of Rh123 dye out of BM cells Rhodamine 123
is inhibited by reserpine and verapamil." To extend these studies to an enriched population of HSCs, verapamil was added to ABM cells loaded with Rh123 dye and the effect on rhodamine efflux was examined on CD34'Thy-I' cells. After 1 hour of efflux in the absence of verapamil, the majority of CD34'Thy-I+ cells became Rh123'""""' (Fig 3A) . By increasing the efflux time to 2 hours, the majority of CD34'Thy-I + cells became Rh 123'" and Rh 123'"'" (Fig 3B) . In marked contrast. no efflux of rhodamine dye was seen in the presence of verapamil (Fig 3C) .
Short-term in vitro hehuvior of Rh123 sul?popltlcrtions. In the kinetic studies of Rh123 efflux described above, it is possible to define at least three subpopulations of CD34' cells: Rh 123'", Rh123""". and Rh123h'. The biologic properties of these subpopulations were examined in both shortterm and long-term in vitro BM culture (LTBMC) assays. Before characterizing three Rh I23 subpopulations in LTBMC. we first tested whether Thy-1 + subpopulations separated by Rh123 staining behaved differently in a short-term BM culture assay. CD34' ABM cells were separated into CD34'Thy-I 'Rh 123'". CD34'Thy-I 'Rh1 23""". CD34'Thy-1 ^Rh l23""", and CD34'Thy-I -Rh 1 23hi subpopulations. These four subpopulations were plated onto SySl murine BM stromal cells and analyzed for the maintenance of primitive cells by expression of CD34 and lack of CD33 antigen expression.I5 One week after coculture. a distinct difference was observed in the ability of the different Rh123 subsets to maintain the CD34'CD33-phenotype (Fig 4) . The CD34'Thy-I 'Rh1 23'" subset had the greatest potential to maintain uncommitted populations of CD34'CD33-cells (-75%. Fig 4A) , whereas the CD34'Thy-1 -Rh 1 23h' fraction maintained few CD34TD33-cells (-696, Fig 4D) . The CD34'Thy-I 'Rh I23""" and CD34'Thy-1 ~R h 123'""' fractions showed a decreasing ability to maintain these uncommitted CD34'CDW cells (Fig 4B and C) . 
Long-term in vitro proliferation of RI1123 subpopdations.
tial of the Rh 123'", Rh 1 23'"Id, and Rh 1 23hi subsets of Results from the short-term assay described indicate that CD34'Lin-cells, an ACDU was used to plate between one CD34'Rh123'" ABM cells were virtually all Thy-l' and and 15 cells into individual wells of a 96-well plate conmaintain a primitive CD34TD33-cell phenotype after 1 taining SyS 1 murine stromal cells. Figure 5A shows the sort week of coculture. To test the long-term proliferative potengates used to isolate these three subsets of CD34'Lin-cells. 
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The kinetics of CAFC development from these three Rh123 subsets was examined from weeks 3 through 6 to 8 and is shown in Fig 5B. The Rh123"'"'CD34'Lin-subset showed the most rapid and extensive proliferative potential early in culture, but eventually declined in CAFC activity. The CD34'Lin-Rh123'" cells initially did not give rise to significant cobblestone areas (3 weeks), but the number of cobblestone areas gradually increased by 5 to 6 weeks. In The results shown in Table I are the plating efficiency of cells in LTBMC, CAFC frequency, and the frequency of cells able to maintain CD34' cells in vitro. Plating efficiency was defined as the frequency of cells that showed any type of proliferation, including cobblestone areas, clusters, and macrophages, during the scoring period ( 2 3 weeks). This plating efficiency indicates the growth of both primitive and committed progenitor cells, whereas CAFC activity correlates with the growth of more primitive progenitors and HSCs." The best plating efficiency was observed in the Rh123""" subset (one of five), compared with Rh123'" (one of six) and Rh 123''' (one of 22). However, the Rh 123'" population generated the highest CAFC frequency (one of 19) and ability to maintain CD34' cells (one of 56), whereas the Rh123""d subset had intermediate activity (one of 42 for CAFC and one of 101 for CD34' cell maintenance). The Rh123h' subset was significantly depleted of CAFC activity (one of 427) and was unable to maintain CD34' cells. Nevertheless, these cells had a relatively high plating efficiency, indicating that these cells have limited proliferation capacity and are therefore more mature progenitor cells.
The cells proliferating in long-term cultures were also harvested and analyzed for expression of CD34. CD33, and CD19 antigens. Figure 6A and B shows a representative analysis of cells from wells initially seeded with CD34'Lin-Rh123'" cells. At both 6 and 8 weeks of culture, CD34'Lin-Rh 123'" cells were characterized by retention of a significant fraction of CD34TD33-cells (Fig 6A and B) . By contrast, Rh123"""CD34'Lin-cells lost the ability to maintain CD34' progenitors. CD19' B-lineage cells were also present among cells derived from the CD34'Lin-Rh I 23"lid (Fig 6C) or CD34'Thy-I 'Rh 123'" ( Fig  6D) populations.
In vivo hioloRic nctiviries qf Rh123 srrhsets. The display of different biologic properties in vitro prompted us to examine the in vivo properties of Rh123-stained CD34' subsets, using the SCID-hu bone model and the in utero sheep transplant model. Because a relatively large number of cells are needed for successful performance of the SCID-hu bone assays, the Rh123'" and Rh 123'""' subsets were combined into one fraction and compared with the Rh123h' cells for functional activity.
Injection of Rh 123-defined subsets into allogeneic human fetal bones engrafted in SCID.mice revealed the BM-repopulating ability and multilineage differentiation potential of the use only. SySl coculture was performed, and CD34'Lin cells from 3 ABM tissues were separated by Rh123 staining. The value of l/frequency is shown (ie, 6.0 instead of one of 6.0). Plating efficiency was defined as the frequency of cells that showed any kind of proliferation, including cobblestone areas, clusters, and macrophages, during the scoring period ( 2 3 wkl. The lower and upper 95% Cl of each frequency analysis is shown.
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Abbreviation: Cl. confidence interval.
CD34"Lin-Rh 123"'""i" stem cell-containing population (Fig  7) . Table 2 shows results from three experiments testing the marrow-engrafting potential of Rh123 subsets of CD34'Lin-ABM cells. In each experiment, all fetal bone implants injected with Rh I23'""""'CD34'Lin-cells showed greater than 1 % donor-derived cells (range, 2% to 86%). In contrast, only one of four bone implants injected with Rh123"'CD34'Lin~ cells showed a very low level of donor-derived cells.
The biologic activity of Rh 123 subsets was also tested on human cells that had engrafted sheep BM following transplantation into developing fetuses in utero. In this experiment. CAFC activity at week 6 was highly enriched in ABM Thy-l 'CD34'Lin-cells (one of 46) and relatively depleted in Thy-1 -CD34'Lin" cells (one of 26 I ).'" These sorted cells were injected into sheep fetuses in utero, and I to 4 weeks after birth BM aspirates were obtained from the lambs and analyzed for the presence of human cells. In one lamb. sufficiently high levels of CD4S' human cells (-4%) were present in the BM aspirate and could be reisolated to analyze the biologic potential of these human cells engrafted in this xenogeneic transplant model.'" Human cells expressing CD34 were stained for Rh 123, and the expected Rh 123'".'" distribution was observed. However, in this particular sample, the Rh12.3'" subset could be further divided into two distinct fractions (Fig 8A) . Therefore, four Rh123 subsets of the CD34'Lin-population were fractionated (Fig 8A) and tested for CAFC activity in LTBMCs. Figure 8B shows the kinetics of CAFC formation obtained from these four different Rh 123 subsets; Rh 123'"'', Rh 123'"". Rh 123"'"'. and Rh123"'. In agreement with the results shown in Fig S. the Rh123"' subset did not possess CAFC activity, whereas the Rh123'"" subset possessed the majority of CAFC activity after prolonged culture. The Rh I23'".' and Rh1 23'"''1 fractions possessed more CAFC activity after shorter periods of incubation, which gradually decreased over time. These results show the maintenance of the biological activity, based on Rh123 retention, and secondary transfer into LTBMCs of human CD34'Thy-I+ BM cells engrafted in xenogeneic sheep BM.
DISCUSSION
In this study, the functional heterogeneity of human CD34' cells was further examined by studying selective efflux of the vital Rh123 dye. Rh 123 efflux from a cell occurs primarily as a consequence of an active transport system such as the P-gp pump encoded by the MDR gene. Verapamil. an inhibitor of the P-gp pump. prevents efflux of Rh123 dye from CD34' cells. Analysis of the different Rh 123 subsets in vitro showed that CAFC activity was most enriched in CD34'Lin-Rh 123'" and Rh I23"'" cells. and relatively depleted in the Rh123'" subset. Rh123 subsets from ABM were plated at one and three cells per well and analyzed for proliferative capacity in vitro. The Rh123'" subset was quiescent at early time points and did not possess the ability to produce cobblestone areas after short periods of incubation. However, Rh 123'" cells did produce cobblestone areas after S to 8 weeks of culture. By contrast, the R h 123""' subset was highly enriched in relatively early (week 3 to 4) CAFC. but was less capable of forming cobblestone areas at later times (6 to 8 weeks). Four-color analysis of the CD34'Thy-1 .L population isolated from ABM and MPB showed that virtually all Thy-l * cells were Rh123'""'"'1. In use only. addition. SCID-hu bone engraftment activity was enriched in the Rh123'"'"'i'' subsets and relatively depleted in CD34'Lin-Rh 1 23hi ABM. Thus, Rh 123'" and Rh I 23""" fractions are both Thy-I + and display distinct properties associated with hematopoietic stem cells.
Previously, it was shown that CD34'Thy-I 'Lin" ABM cells are highly enriched for HSC.".'" This population has also been shown to successfully engraft in fetal sheep after in utero transplantation.'" We show herein that primitive human progenitors isolated from the BM of such chimeric sheep and fractionated based on Rh123 retention retain the biological activity representative of the originally transplanted cells. CAFC activity of human cells isolated from chimeric animals was primarily enriched in the Rh 12.1'" subset and depleted in the Rh1 23h' fraction. Moreover, each fraction displayed a CAFC frequency equivalent to that of phenotypically identical cells of the same phenotype isolated from the primary tissue. These results indicate that primitive human hematopoietic cells maintain a system capable of effluxing Rh123 dye after engraftment and proliferation in sheep BM.
Udomsakdi et al' have reported that LTC-IC were en- The in utero transplantation model into fetal sheep has been a useful in vivo model to show both the homing and engraftment of human HSCs.'"'' Here, we have shown that the CAFC activity of Rh123'" subsets of the primary tissue and human cells isolated following in utero transplantation is similar. Thus, the hierarchy of hematopoietic cells according to Rh123 phenotype was maintained in chimeric sheep, where Rh123'" cells were more primitive than Rh 123"'" cells, and Rh123h' cells constitute more differentiated progenitor cells. These studies also suggest that "fetal" microenvironments are able to maintain CAFC activity in the Rh123In subset, even when the HSCs come from adult donors.
We defined the Rh123"~""" population by P-gp activity. population disappeared when Rh 123 dye efflux was blocked by verapamil, consistent with the findings of Chaudhary and Roninson." That is not to say that mitochondria numbers and/or activity are not also determinants of Rh123 staining in HSC subsets. Visser et all' separated Rh123'" and Rh123h' subsets of primitive murine progenitors and showed that the total mitochondria surface area of the Rh1 23'" subset was much less than that of the Rh123hi subset. Spangrude and Thomas" have also recently shown that mouse HSCs deprived of P-gp activity by inhibitors such as cyclosporine A or verapamil can also be divided into subsets based on Rh123 staining. The lower-staining subsets were enriched in long-term multilineage repopulating activity and had fewer mitochondria, whereas the Rh 123 bright-staining subset had more mitochondria but less LTMR activity." Thus, it is possible that in humans, as in mice, a good correlation exists between the Rh123'" phenotype and low levels of mitochondria and P-gp activities.
The Rh 1231D.ltlid riched in the CD34'Rh 123"'"" but not in the CD34'Rh 1 23hnFh' population of ABM. Conversely, the frequency of clonogenic cells (summation of BFU-E, CFU-GM, and CFU-GEMM) was slightly more enriched in the CD34'Rh123hr'Fh' versus the CD34'Rh123""" subset. ' We observed similar results when Rh123'", Rh 1 23"Id, and Rh 1 23h'CD34'Lin-ABM subsets were plated in semisolid media (data not shown). These studies strongly suggest that both LTC-IC and CAFC activity are more representative of human HSC and primitive progenitor cell activities.
Short-term stromal coculture assays were also performed on the Rh123 subsets. CD34'Thy-1 'Rh123'" cells were able to maintain a cell population in culture with a primitive CD34'CD33-. Verfaillie and Millei' have also shown that CD34'CD33-cells derived from CD34'HLA-DR-ABM contain secondary LTC-IC activity. Taken together, these data indicate that primitive ABM cells capable of long-term culture activity as measured by CAFC correlate with a CD34TD33-phenotype seen at early times in a short-term assay.
